Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Jenkins

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Comparative Effectiveness Research|March 19, 2020
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulantsVictoria Allan, Sreeram V Ramagopalan, Jack Mardekian, et al.
Current Medical Research and Opinion|September 28, 2024
Evaluation of rimegepant utilization patterns and patient characteristics among new users: a United States administrative claims-based studyJessica Ailani, Motomori Lewis, Feng Dai, et al.
International Journal of Environmental Research and Public Health|October 17, 2015
Exploring Ecosystems and Health by Shifting to a Regional Focus: Perspectives from the Oceania EcoHealth ChapterJonathan Kingsley, Rebecca Patrick, Pierre Horwitz, et al.
Cephalalgia : an International Journal of Headache|June 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the USStewart J Tepper, Aaron Jenkins, Simon Dagenais, et al.
Cephalalgia : an International Journal of Headache|December 5, 2024
The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness SurveyAstrid Gendolla, Joshua D Brown, Amanda R Mercadante, et al.
Novartis Foundation Symposium|January 10, 2004
Non-rod, non-cone photoreception in rodents and teleost fishRussell G Foster, Mark Hankins, Robert J Lucas, et al.
BMC Public Health|January 21, 2025
The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness surveyGianluca Coppola, Joshua D Brown, Amanda R Mercadante, et al.
Journal of Medical Economics|April 9, 2024
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UKKarissa Johnston, Lauren C Powell, Evan Popoff, et al.
European Journal of Internal Medicine|December 1, 2022
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES studySteven Deitelzweig, Allison Keshishian, Amiee Kang, et al.
Headache|November 27, 2024
Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature reviewRichard B Lipton, Astrid Gendolla, Lucy Abraham, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Comparative Effectiveness Research|March 19, 2020
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulantsVictoria Allan, Sreeram V Ramagopalan, Jack Mardekian, et al.
Current Medical Research and Opinion|September 28, 2024
Evaluation of rimegepant utilization patterns and patient characteristics among new users: a United States administrative claims-based studyJessica Ailani, Motomori Lewis, Feng Dai, et al.
International Journal of Environmental Research and Public Health|October 17, 2015
Exploring Ecosystems and Health by Shifting to a Regional Focus: Perspectives from the Oceania EcoHealth ChapterJonathan Kingsley, Rebecca Patrick, Pierre Horwitz, et al.
Cephalalgia : an International Journal of Headache|June 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the USStewart J Tepper, Aaron Jenkins, Simon Dagenais, et al.
Cephalalgia : an International Journal of Headache|December 5, 2024
The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness SurveyAstrid Gendolla, Joshua D Brown, Amanda R Mercadante, et al.
Novartis Foundation Symposium|January 10, 2004
Non-rod, non-cone photoreception in rodents and teleost fishRussell G Foster, Mark Hankins, Robert J Lucas, et al.
BMC Public Health|January 21, 2025
The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness surveyGianluca Coppola, Joshua D Brown, Amanda R Mercadante, et al.
Journal of Medical Economics|April 9, 2024
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UKKarissa Johnston, Lauren C Powell, Evan Popoff, et al.
European Journal of Internal Medicine|December 1, 2022
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES studySteven Deitelzweig, Allison Keshishian, Amiee Kang, et al.
Headache|November 27, 2024
Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature reviewRichard B Lipton, Astrid Gendolla, Lucy Abraham, et al.
Pageof 3